Price:
Rs. 112,360.00
Sample Type: EDTA Whole Blood , Tissue
Fasting Not Required
Notes:N8299
Frequently Asked Questions (FAQ's):
What does the NextGen Advanced Immunotherapy Panel at Metropolis Healthcare include?
It assesses TMB, MSI, PD-L1 expression, and somatic mutations to guide both targeted and immunotherapy decisions.
How does Metropolis Healthcare perform this panel?
Metropolis Healthcare combines high-depth NGS for genomic profiling with validated IHC for PD-L1 to deliver accurate biomarker results.
Who should consider taking this test at Metropolis Healthcare?
Patients with solid tumors needing detailed molecular and immunotherapy insights for personalized treatment planning should consider this panel.
Is fasting required for the Advanced Immunotherapy Panel at Metropolis Healthcare?
No fasting is needed; the test uses tumor tissue or blood samples as per clinical guidance.
How long do results take at Metropolis Healthcare?
Results typically take 2–3 weeks due to comprehensive genomic sequencing and immunohistochemistry evaluation.
Can this test at Metropolis Healthcare help guide immunotherapy decisions?
Yes, TMB, MSI, and PD-L1 levels assist clinicians in selecting appropriate immune checkpoint inhibitor therapies.
How accurate is the NextGen Advanced Immunotherapy Panel at Metropolis Healthcare?
Metropolis Healthcare ensures high accuracy through validated NGS and IHC protocols under strict quality control.
Does this panel support long-term cancer management at Metropolis Healthcare?
Yes, the combined molecular and immunotherapy insights enable personalized treatment strategies and ongoing therapy optimization.